652 related articles for article (PubMed ID: 15827035)
1. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
MacDonald TM; Hawkey CJ; Ford I; McMurray JJV; Scheiman JM; Hallas J; Findlay E; Grobbee DE; Hobbs FDR; Ralston SH; Reid DM; Walters MR; Webster J; Ruschitzka F; Ritchie LD; Perez-Gutthann S; Connolly E; Greenlaw N; Wilson A; Wei L; Mackenzie IS
Eur Heart J; 2017 Jun; 38(23):1843-1850. PubMed ID: 27705888
[TBL] [Abstract][Full Text] [Related]
3. Are non-steroidal anti-inflammatory drugs always necessary? A general practice survey.
Swift GL; Rhodes J
Br J Clin Pract; 1992; 46(2):92-4. PubMed ID: 1457317
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside.
Beardon PH; Brown SV; McDevitt DG
Q J Med; 1989 Jun; 71(266):497-505. PubMed ID: 2602546
[TBL] [Abstract][Full Text] [Related]
5. Identification of patients at risk for gastropathy associated with NSAID use.
Fries JF; Miller SR; Spitz PW; Williams CA; Hubert HB; Bloch DA
J Rheumatol Suppl; 1990 Feb; 20():12-9. PubMed ID: 2325051
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
Puccetti L; Ciompi ML
Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
[TBL] [Abstract][Full Text] [Related]
7. Non steroidal anti-inflammatory drugs. Risk factors versus benefits.
Savvas P; Brooks PM
Aust Fam Physician; 1991 Dec; 20(12):1726-9, 1732-3. PubMed ID: 1805774
[TBL] [Abstract][Full Text] [Related]
8. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
[TBL] [Abstract][Full Text] [Related]
9. Intestinal mucosal permeability in inflammatory rheumatic diseases. I. Role of antiinflammatory drugs.
Mielants H; Goemaere S; De Vos M; Schelstraete K; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):389-93. PubMed ID: 1906938
[TBL] [Abstract][Full Text] [Related]
10. Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.
Llewellyn JG; Pritchard MH
J Rheumatol; 1988 Apr; 15(4):691-4. PubMed ID: 3397979
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors.
Hawkey CJ; Langman MJ
Gut; 2003 Apr; 52(4):600-8. PubMed ID: 12631678
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value.
Luggen ME; Gartside PS; Hess EV
J Rheumatol; 1989 Dec; 16(12):1565-9. PubMed ID: 2625688
[TBL] [Abstract][Full Text] [Related]
13. Adverse events with droxicam in the early clinical trials.
Sánchez J; Bartlett A; Costa A; Estruch J; Estiarte R; Soucheiron C
Eur J Rheumatol Inflamm; 1991; 11(4):50-8. PubMed ID: 1365491
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal antiinflammatory drugs: benefit/risk evaluation in rheumatic diseases.
Fenner H
J Rheumatol Suppl; 1992 Jan; 32():98-9. PubMed ID: 1613741
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs: assessment of risks.
Inman WH
Eur J Rheumatol Inflamm; 1987; 8(1):71-85. PubMed ID: 2957207
[TBL] [Abstract][Full Text] [Related]
16. An updated safety profile of etodolac in several thousand patients.
Schattenkirchner M
Eur J Rheumatol Inflamm; 1990; 10(1):56-65. PubMed ID: 2146132
[TBL] [Abstract][Full Text] [Related]
17. Prescribing behaviors of family physicians in the treatment of osteoarthritis.
Holt WS; Mazzuca SA
Fam Med; 1992; 24(7):524-7. PubMed ID: 1397826
[TBL] [Abstract][Full Text] [Related]
18. [NSAIDs (non steroidal anti-inflammatory drugs) for the treatment of rheumatoid arthritis].
Ito Y; Yukinari T; Yanagawa A; Nakagawa T
Nihon Rinsho; 1992 Mar; 50(3):509-14. PubMed ID: 1588739
[TBL] [Abstract][Full Text] [Related]
19. Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
Sobel RE; Lovell DJ; Brunner HI; Weiss JE; Morris PW; Gottlieb BS; Chalom EC; Jung LK; Onel KB; Petiniot L; Goldsmith DP; Nanda K; Shishov M; Abramsky S; Young JP; Giannini EH;
Pediatr Rheumatol Online J; 2014; 12():29. PubMed ID: 25057265
[TBL] [Abstract][Full Text] [Related]
20. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study.
Martin RM; Biswas P; Mann RD
Br J Clin Pharmacol; 2000 Jul; 50(1):35-42. PubMed ID: 10886116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
